162 related articles for article (PubMed ID: 36625099)
1. Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry.
Chu HW; Chang KP; Yen WC; Liu HP; Chan XY; Liu CR; Hung CM; Wu CC
Proteomics; 2023 May; 23(9):e2200321. PubMed ID: 36625099
[TBL] [Abstract][Full Text] [Related]
2. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
[TBL] [Abstract][Full Text] [Related]
3. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma.
Wu CC; Chang YT; Chang KP; Liu YL; Liu HP; Lee IL; Yu JS; Chiang WF
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1569-78. PubMed ID: 24859869
[TBL] [Abstract][Full Text] [Related]
4. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
5. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
Hsu CW; Yu JS; Peng PH; Liu SC; Chang YS; Chang KP; Wu CC
J Proteome Res; 2014 Nov; 13(11):4796-807. PubMed ID: 24708169
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
[TBL] [Abstract][Full Text] [Related]
8. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
10. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
11. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
12. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
Momen-Heravi F; Trachtenberg AJ; Kuo WP; Cheng YS
J Dent Res; 2014 Jul; 93(7 Suppl):86S-93S. PubMed ID: 24718111
[TBL] [Abstract][Full Text] [Related]
13. Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma.
Hsueh PC; Chang KP; Liu HP; Chiang WF; Chan XY; Hung CM; Chu LJ; Wu CC
Front Oncol; 2022; 12():968570. PubMed ID: 36387116
[TBL] [Abstract][Full Text] [Related]
14. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
[TBL] [Abstract][Full Text] [Related]
15. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
16. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
17. Salivary proteomics for oral cancer biomarker discovery.
Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
[TBL] [Abstract][Full Text] [Related]
18. In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors.
Ploypetch S; Roytrakul S; Phaonakrop N; Kittisenachai S; Leetanasaksakul K; Pisamai S; Kalpravidh C; Rungsipipat A; Suriyaphol G
BMC Vet Res; 2020 Sep; 16(1):335. PubMed ID: 32928212
[TBL] [Abstract][Full Text] [Related]
19. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
20. Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.
Hsiao YC; Chi LM; Chien KY; Chiang WF; Chen SF; Chuang YN; Lin SY; Wu CC; Chang YT; Chu LJ; Chen YT; Chia SL; Chien CY; Chang KP; Chang YS; Yu JS
Mol Cell Proteomics; 2017 Oct; 16(10):1829-1849. PubMed ID: 28821604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]